What Is Scilex Holding Company (SCLX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Scilex Holding Company's intrinsic value is estimated at $23.12, suggesting a +144.9% average upside from the current price of $9.44. While 5 models see room for appreciation, model agreement is not unanimous as 2 models flag potential overvaluation. Model dispersion is worth noting: EROIC targets $50.17 (+431.5%), versus Regime Cross at $1.36 (-85.6%). This +517.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About SCLX?
7 of 13 models are currently active for SCLX. Of these, 5 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates SCLX's intrinsic value at $14.72, implying +56.0% upside from the current price. See which stocks rank higher →
How Does SCLX Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, SCLX ranks #72 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Scilex Holding Company operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is SCLX a Value Trap?
CirclFi's Value Trap algorithm assigns SCLX a score of 41/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
7 of 13 models are active for Scilex Holding Company. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Scilex Holding Company earns a quality score of 5.2/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.
The gap between the most bullish and bearish model spans +517.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every SCLX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across SCLX's 7 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad